BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37202930)

  • 1. The potential impact of vaccination on tuberculosis burden in India: A modelling analysis.
    Arinaminpathy N; Rade K; Kumar R; Joshi RP; Rao R
    Indian J Med Res; 2023; 157(2&3):119-126. PubMed ID: 37202930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01
    Clark RA; Weerasuriya CK; Portnoy A; Mukandavire C; Quaife M; Bakker R; Scarponi D; Harris RC; Rade K; Mattoo SK; Tumu D; Menzies NA; White RG
    BMC Med; 2023 Aug; 21(1):288. PubMed ID: 37542319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting the Chingleput BCG vaccination trial for the impact of BCG revaccination on the incidence of tuberculosis disease.
    Velayutham B; Thiruvengadam K; Kumaran PP; Watson B; Rajendran K; Padmapriyadarsini C
    Indian J Med Res; 2023; 157(2&3):152-159. PubMed ID: 36124494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered.
    Dye C
    J R Soc Interface; 2013 Oct; 10(87):20130365. PubMed ID: 23904584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01
    Clark RA; Weerasuriya CK; Portnoy A; Mukandavire C; Quaife M; Bakker R; Scarponi D; Harris RC; Rade K; Mattoo SK; Tumu D; Menzies NA; White RG
    medRxiv; 2023 Jul; ():. PubMed ID: 36865172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
    MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities.
    Faust L; Schreiber Y; Bocking N
    BMC Public Health; 2019 Nov; 19(1):1504. PubMed ID: 31711446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential impact of spatially targeted adult tuberculosis vaccine in Gujarat, India.
    Shrestha S; Chatterjee S; Rao KD; Dowdy DW
    J R Soc Interface; 2016 Mar; 13(116):. PubMed ID: 27009179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
    Fu H; Lin HH; Hallett TB; Arinaminpathy N
    Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential impact of tuberculosis vaccines in China, South Africa, and India.
    Harris RC; Sumner T; Knight GM; Zhang H; White RG
    Sci Transl Med; 2020 Oct; 12(564):. PubMed ID: 33028708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of BCG vaccination on tuberculin surveys to estimate the annual risk of tuberculosis infection in south India.
    Gopi PG; Subramani R; Nataraj T; Narayanan PR
    Indian J Med Res; 2006 Jul; 124(1):71-6. PubMed ID: 16926459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current perspective in tuberculosis vaccine development for high TB endemic regions.
    Husain AA; Daginawala HF; Singh L; Kashyap RS
    Tuberculosis (Edinb); 2016 May; 98():149-58. PubMed ID: 27156631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coverage of childhood vaccination among children aged 12-23 months, Tamil Nadu, 2015, India.
    Murhekar MV; Kamaraj P; Kanagasabai K; Elavarasu G; Rajasekar TD; Boopathi K; Mehendale S
    Indian J Med Res; 2017 Mar; 145(3):377-386. PubMed ID: 28749402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling the health and economic impacts ofM72/AS01
    Sumner T; Clark RA; Mukandavire C; Portnoy A; Weerasuriya CK; Bakker R; Scarponi D; Hatherill M; Menzies NA; White RG
    Vaccine; 2024 Feb; 42(6):1311-1318. PubMed ID: 38307747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland.
    Sweeney E; Dahly D; Seddiq N; Corcoran G; Horgan M; Sadlier C
    BMC Infect Dis; 2019 May; 19(1):397. PubMed ID: 31072396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study.
    Clark RA; Portnoy A; Weerasuriya CK; Sumner T; Bakker R; Harris RC; Rade K; Mattoo SK; Tumu D; Menzies NA; White RG
    medRxiv; 2023 Sep; ():. PubMed ID: 37808744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of sex, age & nontuberculous infection at intake on the efficacy of BCG: re-analysis of 15-year data from a double-blind randomized control trial in South India.
    Narayanan PR
    Indian J Med Res; 2006 Feb; 123(2):119-24. PubMed ID: 16575109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK.
    Mangtani P; Nguipdop-Djomo P; Keogh RH; Trinder L; Smith PG; Fine PE; Sterne J; Abubakar I; Vynnycky E; Watson J; Elliman D; Lipman M; Rodrigues LC
    Health Technol Assess; 2017 Jul; 21(39):1-54. PubMed ID: 28738015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCG vaccination: An update on current Australian practices.
    Taylor JW; Curtis N; Denholm J
    Aust J Gen Pract; 2020 Oct; 49(10):651-655. PubMed ID: 33015679
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.